Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Mutations in certain receptors can cause diseases and offer new treatment options.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

CT scans can find serious prostate cancer even when PSA levels are low.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.